Reply to the letter by Ferraro and Biganzoli
- PMID: 35297161
- DOI: 10.1111/bju.15642
Reply to the letter by Ferraro and Biganzoli
Comment on
-
Association between one-time prostate-specific antigen (PSA) test with free/total PSA ratio and prostate cancer mortality: A 30-year prospective cohort study.BJU Int. 2021 Oct;128(4):490-496. doi: 10.1111/bju.15417. Epub 2021 May 6. BJU Int. 2021. PMID: 33811738
-
Association between total prostate-specific antigen (tPSA), free/tPSA, and prostate cancer mortality.BJU Int. 2022 Mar;129(3):418. doi: 10.1111/bju.15611. BJU Int. 2022. PMID: 35297160 No abstract available.
References
-
- Ferraro S, Biganzoli EM. Association between total prostate-specific antigen (tPSA), free/tPSA, and prostate cancer mortality. BJU Int 2021; 52: 467-9.
-
- Lundgren PO, Kjellman A, Norming U, Gustafsson O. Association between one-time prostate-specific antigen (PSA) test with free/total PSA ratio and prostate cancer mortality: a 30-year prospective cohort study. BJU Int 2021; 128: 490-6.
-
- Garrido MM, Marta JC, Ribeiro RM, Pinheiro LC, Holdenrieder S, Guimarães JT. Comparison of three assays for total and free PSA using hybritech and WHO calibrations. In Vivo 2021; 35: 3431-9
-
- Forde JC, Marignol L, Blake O et al. Standardization of assay methods reduces variability of total PSA measurements: an Irish study. BJU Int 2012; 110: 644-50
-
- Leewansangtong S, Goktas S, Lepoff R, Holthaus K, Crawford ED. Comparability of serum prostate-specific antigen measurement between the hybritech Tandem-R and Abbott AxSYM assays. Urology 1998; 52: 467-9
Publication types
LinkOut - more resources
Full Text Sources
